Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

154 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Long-Term Omalizumab Treatment: A Multicenter, Real-Life, 5-Year Trial.
Yorgancıoğlu A, Öner Erkekol F, Mungan D, Erdinç M, Gemicioğlu B, Özşeker ZF, Bayrak Değirmenci P, Naycı S, Çilli A, Erdenen F, Kırmaz C, Ediger D, Yalçın AD, Büyüköztürk S, Öztürk S, Güleç M, Işık SR, Kalyoncu AF, Göksel Ö, Aydın Ö, Havlucu Y, Baloğlu Ar İ, Erdoğdu A. Yorgancıoğlu A, et al. Among authors: kalyoncu af. Int Arch Allergy Immunol. 2018;176(3-4):225-233. doi: 10.1159/000488349. Epub 2018 May 17. Int Arch Allergy Immunol. 2018. PMID: 29772578
Multidrug-induced erythema multiforme.
Isik SR, Karakaya G, Erkin G, Kalyoncu AF. Isik SR, et al. Among authors: kalyoncu af. J Investig Allergol Clin Immunol. 2007;17(3):196-8. J Investig Allergol Clin Immunol. 2007. PMID: 17583109 Free article.
Tolerability of lumiracoxib in patients with analgesic intolerance.
Celikel S, Isik SR, Karakaya G, Kalyoncu AF. Celikel S, et al. Among authors: kalyoncu af. J Investig Allergol Clin Immunol. 2008;18(4):318-9. J Investig Allergol Clin Immunol. 2008. PMID: 18714545 Free article. No abstract available.
154 results